Jialei W. Weng
Hangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Suppression of macrophage membrane cholesterol efflux by SLAMF7-induced IL-7 signaling improves immunotherapy efficacy in hepatocellular carcinoma.
Journal: Hepatology international
Published: March 17, 2026
Erratum: HMOX1+ macrophages determine immunosuppressive microenvironment and immunotherapy efficacy in hepatocellular carcinoma.
Journal: Hepatology communications
Published: January 02, 2026
HTRA1+ Macrophages Induce T-cell Egress through CRIP1/NF-κB/CXCL12 to Limit the Effects of Immunotherapy in Triple-Negative Breast Cancer.
Journal: Cancer immunology research
Published: September 18, 2025
CXCL2 affects macrophage antitumor function and immunotherapy efficacy in esophageal squamous cell carcinoma through calcium signaling.
Journal: Frontiers in immunology
Published: August 29, 2025
Single-cell insights into tumor microenvironment heterogeneity and plasticity: transforming precision therapy in gastrointestinal cancers.
Journal: Journal of experimental & clinical cancer research : CR
Published: July 31, 2025
Galectin-4 drives anti-PD-L1/BVZ resistance by regulating metabolic adaptation and tumour-associated neutrophils in hepatocellular carcinoma.
Journal: Gut
Published: July 09, 2025
FMO2+ cancer-associated fibroblasts sensitize anti-PD-1 therapy in patients with hepatocellular carcinoma.
Journal: Journal for immunotherapy of cancer
Published: April 14, 2025
AKR1C3 enhances radioresistance in esophageal adenocarcinoma via inhibiting ferroptosis through suppressing TRIM21-mediated ubiquitination of HSPA5.
Journal: Cell death & disease
Published: December 09, 2024
WWOX tuning of oleic acid signaling orchestrates immunosuppressive macrophage polarization and sensitizes hepatocellular carcinoma to immunotherapy.
Journal: Journal for immunotherapy of cancer
Published: October 13, 2024
AKAP12 positive fibroblast determines immunosuppressive contexture and immunotherapy response in patients with TNBC by promoting macrophage M2 polarization.
Journal: Journal for immunotherapy of cancer
Published: October 03, 2024
FGFR2 fusion/rearrangement is associated with favorable prognosis and immunoactivation in patients with intrahepatic cholangiocarcinoma.
Journal: The oncologist
Published: March 02, 2024
Last Updated: 09/26/2026